Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. - Wikidata - wikimedia - TriplyDB

Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.

Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.

http://www.wikidata.org/entity/Q34650241

about

Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histology Ultra-High-Field MR Neuroimaging.Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain Calcification in high grade gliomas treated with bevacizumab.Quantitative Susceptibility Mapping: Concepts and Applications.Advanced MR Imaging in Neuro-oncology.Overview of quantitative susceptibility mapping.The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping.Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data.Diagnostic accuracy of susceptibility-weighted magnetic resonance imaging for the evaluation of pineal gland calcification.Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors Calcification in Globus Pallidus and Putamen of Multiple Sclerosis Patients Versus Healthy Subjects Using Quantitative Susceptibility Mapping.Radiological imaging features of glioblastoma with oligodendroglioma component: a comparison with conventional glioblastoma.Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis.Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status Stability of R2* and quantitative susceptibility mapping of the brain tissue in a large scale multi-center study.Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages.Nuclei-specific deposits of iron and calcium in the rat thalamus after status epilepticus revealed with quantitative susceptibility mapping (QSM).Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters.Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.Potential of quantitative susceptibility mapping for detection of prostatic calcifications.An iterative spherical mean value method for background field removal in MRI.Effects of white matter microstructure on phase and susceptibility maps.Theoretical model of the single spin-echo relaxation time for spherical magnetic perturbers.Susceptibility-Based Differentiation of Intracranial Calcification and Hemorrhage in Pediatric Patients.Investigating magnetic susceptibility of human knee joint at 7 Tesla.Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy.Lesion magnetic susceptibility response to hyperoxic challenge: A biomarker for malignant brain tumor microenvironment?The impact of white matter fiber orientation in single-acquisition quantitative susceptibility mapping.Infiltrative patterns of glioblastoma: Identification of tumor progress using apparent diffusion coefficient histograms.Susceptibility Weighted MRI in Rodents at 9.4 T.[Computational neuroanatomy and microstructure imaging using magnetic resonance imaging].

P2860

Q28544667-E8D4A7F9-B62B-441F-880B-70652FB807C2 Q30401687-2BF1E91A-BEEB-4790-A431-52350E3DA8C0 Q30837513-470EE28E-0BBF-4B6A-A534-217677E4E862 Q30856540-A0FADEF9-7B8C-4ED6-AE73-2790097202FC Q30943748-3A7A8259-0F1A-49CE-991D-80EA1E32F0B6 Q30982002-5EC627DC-3275-4F8F-9775-6E85F9C88ABF Q30983681-6C14D279-8BB0-4E6F-9B6B-45CDEB4BC378 Q31115799-0C370E2D-8B12-4DDA-9172-8B02AA2BD6D7 Q31146333-30C39316-088C-4E3D-AEC3-B710757E9E42 Q33698886-E73FF5EC-A3FF-45CA-BC25-60EC375AB599 Q34495438-0580B14E-AF0A-4944-9CC9-055DC4932F4D Q34626246-A9B0D823-7A6C-4D0E-8F85-03B61B881C5C Q35521721-B2FDF728-5242-4F25-A701-119A895F91C7 Q36297808-DBF33F1C-21B3-48A7-8BEB-8119C1F31603 Q36302815-99EE90D9-EA38-4C2C-B9BD-55D6CA297501 Q36322681-6395ED99-45C0-4C6C-B4BD-1F73D79D9B72 Q37424059-5302571A-2976-4A25-AAB8-FBA251E3E04E Q37436717-8583306F-F061-41D2-A425-526E007553D1 Q37497458-02C7DF03-9FC7-428B-9676-777164FA3DDE Q37677994-0C2EC4D8-D13F-4FE3-84A3-614F8FA9C628 Q37724037-F5E6536F-3555-4C9C-97B7-232E495EE358 Q38632703-F589E712-E616-4FCD-AD96-12F788331309 Q38683194-46E9536A-8E75-4A02-B3D6-9224F2109AFF Q38744249-B1D8F389-A56F-43E4-BBA4-E294D53DB329 Q38844807-E7253AE5-B16F-4B3E-8D92-1461F5BFD95B Q39179797-92E06DD5-5D40-4B45-AB85-CF2D6447491A Q39325304-E0D2B634-E2E3-4475-A61D-61F5486858C8 Q39382061-35DDF460-3C82-4ADB-BCB1-6A6B5B3DA68A Q39600655-06441667-157D-4405-AEB6-C446EEA9A1BA Q39749251-374E995D-D1FD-4A79-A661-9B0ADB6EA3DF Q41858949-83BFEA69-56AE-47F8-B562-5D778816FB75 Q43426820-17CF11D2-8918-4B81-9859-07B9DA9DB1A1 Q44673304-12D2CF3F-637F-457A-8E78-B0F4CF0ECBEA Q45969253-786B850A-8D0F-4FA6-A7DE-0E36B932C1D1 Q47162047-A491421E-C1F0-4410-924E-FC536337A7D0 Q47267468-FE0C6F7C-BA4C-4D3B-85E1-0F2FBC364A62 Q47688746-3FDF9940-2A8B-4610-8841-7C824F9B3B16 Q48941681-49FBC0AD-E882-48D8-A2CC-C3385F7747ED Q50012218-82A33FBE-1429-4C9A-A20E-8BD83FF96C1B Q50526101-4D4CA755-93C8-473C-B8D2-FBBA8A27DC20

P2860

Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.

http://www.wikidata.org/entity/Q34650241

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Quantitative susceptibility ma ...... in patients with glioblastoma.

@ast

Quantitative susceptibility ma ...... in patients with glioblastoma.

@en

Quantitative susceptibility ma ...... in patients with glioblastoma.

@nl

type

label

Quantitative susceptibility ma ...... in patients with glioblastoma.

@ast

Quantitative susceptibility ma ...... in patients with glioblastoma.

@en

Quantitative susceptibility ma ...... in patients with glioblastoma.

@nl

prefLabel

Quantitative susceptibility ma ...... in patients with glioblastoma.

@ast

Quantitative susceptibility ma ...... in patients with glioblastoma.

@en

Quantitative susceptibility ma ...... in patients with glioblastoma.

@nl

P1433

Q34650241-5B205FE3-6040-4F53-A5CC-E63715F1770B

P1476

Q34650241-888B95E0-132E-48FD-AF0F-5B30055EB719

P2093

Q34650241-129300B7-65D1-4D04-B14F-B309B33FF92A

Q34650241-1A097A82-7B77-4005-B571-122C325BF804

Q34650241-6468B595-B520-4CB8-BAFE-0DC2846DAB04

Q34650241-6BE5A6F7-1BA3-42AF-B465-60345404EEA4

Q34650241-77E8EDF5-3563-4F84-8D2D-8DBF5567BF28

P2860

Q34650241-08963050-DB4A-4109-8BB8-D66649489611

Q34650241-209AE5C5-6FE8-4080-BCA7-8CA5309FB961

Q34650241-224D2FEE-D273-4990-BE97-28ED04F47A87

Q34650241-27A72251-F624-47A6-BE78-E771A6FDA3DA

Q34650241-2A198253-E02F-49E0-A544-CB4EBF0F6011

Q34650241-2BE7678B-BAD4-4997-818D-63CE70DCFB63

Q34650241-2C939EC7-096A-4EF8-A21F-9A070FB41FA1

Q34650241-2D98B9F5-45EC-4EA8-9E2C-03AAABAEAF65

Q34650241-2E1EFAFE-F524-4E2C-AFC5-C3DD7EF528D9

Q34650241-325B5DBE-BA44-40D5-A6C4-5A1E1B923097

P304

Q34650241-C2700CBD-6311-402E-811C-8B779AD6C210

P31

Q34650241-CE54F071-803F-4118-9167-A974E5DB3AFF

P356

Q34650241-174F419B-C5E6-4F13-914B-C0A0DB100BA9

P407

Q34650241-2A03CBB9-48BB-4F15-AD7D-7F5708EF1A38

P433

Q34650241-B850C013-7436-4FB7-A8DC-C87F7A65C340

P478

Q34650241-71E390DD-77D8-4E57-BDC4-F5568BA914F6

P50

Q34650241-0D8196D2-B1CA-4C6B-BB51-79858CB7FB22

Q34650241-0D9DFD29-3FB9-4C3A-9633-6E3D11A47F1B

Q34650241-21182555-75FE-4F6D-9088-B6F8A7F248A8

Q34650241-3CE11A77-A882-4686-8B89-5CE9470F2694

Q34650241-5ACA66F3-3609-4B55-A064-35FA1941A171

Q34650241-8A211C3B-159F-4392-B061-2986DF4131C6

Q34650241-A43FFCCF-8A96-45A8-AA9A-DDC61361CD35

Q34650241-AF4B7BA6-4F28-4444-B8F0-5A8CD88EBCE2

P577

Q34650241-69FB87F4-3606-4585-BF27-DDD06314E884

P5875

Q34650241-CA8C847C-32DB-45CF-995E-A41901A9D1A1

P698

Q34650241-D33A4955-B1E9-48B5-88A9-ED35B4E58046

P932

Q34650241-4B6DF4BC-4FA1-499C-BF0B-1E418CDABCEE

P356

JOURNAL.PONE.0057924

P1433

P1476

Quantitative susceptibility ma ...... in patients with glioblastoma.

@en

P2093

Ferdinand Schweser

http://www.w3.org/2001/XMLSchema#string

Heinz-Peter Schlemmer

http://www.w3.org/2001/XMLSchema#string

Mario Abello

http://www.w3.org/2001/XMLSchema#string

Matthias Roethke

http://www.w3.org/2001/XMLSchema#string

Sabine Heiland

http://www.w3.org/2001/XMLSchema#string

P2860

Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent

Generalized autocalibrating partially parallel acquisitions (GRAPPA)

The 2007 WHO classification of tumours of the central nervous system

Malignant gliomas in adults

Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T(1), T(2), T*(2), and non-Lorentzian signal behavior.

Susceptibility weighted imaging (SWI).

Informatics in Radiology: GUIBOLD: a graphical user interface for image reconstruction and data analysis in susceptibility-weighted MR imaging.

Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T.

High-resolution BOLD venographic imaging: a window into brain function.

Susceptibility mapping as a means to visualize veins and quantify oxygen saturation.

P304

e57924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0057924

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Benedikt Wiestler

Martin Bendszus

Alexander Radbruch

Jürgen R Reichenbach

Andreas Deistung

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106419

http://www.w3.org/2001/XMLSchema#string

P698

23555565

http://www.w3.org/2001/XMLSchema#string

P932

3605431

http://www.w3.org/2001/XMLSchema#string